Effectiveness and Mechanism of Online Peer Companion Intervention on Children With Autism Spectrum Disorders
Launched by PEKING UNIVERSITY · Nov 19, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a program called Online Peer Companion Intervention (OPCI) to see how it helps children with Autism Spectrum Disorders (ASD). The main goals are to find out if this online support can improve the social skills and mental health of children with mild ASD, as well as to see how it affects the social abilities and mental health of typically developing children and their parents. Researchers want to understand how this program works to benefit these children.
To participate, children with mild ASD should be between 7 and 15 years old, able to communicate well with others, and have access to a device like a phone or tablet for online sessions. Meanwhile, typically developing children eligible for the study are aged 9 to 18, outgoing, and also able to use electronic devices. Participants can expect to engage in online activities that encourage social interaction and support, which may help improve their social skills and overall well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria of ASD Children:
- • 7-15 years old and diagnosed as mild ASD;
- • Basic ability to speak independently and fluently communicate with peers;
- • Could use mobile phones, tablets, computers, or other electronic devices for this online intervention.
- Exclusion Criteria of ASD Children:
- • Diagnosed as moderate or severe ASD;
- • Unable or unwilling to communicate with peers independently
- • No phones or other alternative electronic devices for the intervention Inclusion
- Criteria of Ordinary Children:
- • 9-18 years old with normal development, no diagnosis of ASD, learning disabilities, ADHD, and other mental disorders;
- • Lively and outgoing, able to assume the role of topic organizer in communication with peers;
- • Could use mobile phones, tablets, computers, or other electronic devices for this online intervention.
- • Exclusion Criteria of Ordinary Children
- • Diagnosis of ASD or other neurodevelopmental and mental disorders;
- • Introverted or unwilling to play with peer ASD children
- • No phones or other alternative electronic devices for the intervention
About Peking University
Peking University is a prestigious institution located in Beijing, China, recognized for its commitment to advancing medical research and education. As a clinical trial sponsor, Peking University leverages its extensive academic resources and collaborative networks to drive innovative healthcare solutions. The university's focus on rigorous scientific methodologies and adherence to ethical standards ensures the integrity and reliability of its clinical research initiatives. By fostering interdisciplinary partnerships, Peking University aims to translate groundbreaking discoveries into tangible health benefits, contributing to the global advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported